Table of Contents
What changed
Revenue fell 25.1% to $196.0m from $261.8m, and operating earnings were effectively wiped out: EBITDA dropped to $0.6m from $21.2m (-97.2%), and the group swung to a PBT loss of $14.3m from a $7.5m profit. NPAT was a $10.4m loss versus a $5.3m profit a year ago, a swing of $15.7m. Operating cash flow held up relatively better, falling 40.2% to $23.1m, and capex was broadly steady at $3.9m, producing pre-lease free cash flow of $19.3m. Cash and equivalents fell to $17.5m from $26.3m, with the group still net cash and no borrowings drawn against its $100m facility. Total equity declined 10.6% to $185.2m. No interim dividend was declared, versus 4.0 cents per share in HY24.
What matters
- Operating earnings have effectively gone to zero. EBITDA of $0.6m on $196.0m of revenue implies the cost base is barely covered by gross profit at current volumes. The PBT loss of $14.3m is the cleaner operating read; the tax credit of ~$3.9m narrowed the gap to the NPAT loss but does not change the underlying picture.
- Inventory is heavy relative to current run-rate. Inventory days rose to 101.8 from 89.4 (+12.4 days), even after the inventory balance itself fell 14.8% to $109.6m. Receivable days were essentially flat at 39. Working capital release is what protected operating cash flow as earnings collapsed.
- Balance sheet resilience is the offset. The group remains net cash at $17.5m with an undrawn $100m facility, which funds the announced acquisition (referenced in the release header but not quantified in the supplied data) and gives time for a cyclical recovery. Return on equity turned negative at -5.6%.
Expectations
No formal earnings or revenue guidance was disclosed in the supplied excerpts. On shape, FY24 was not second-half weighted on revenue (HY24 was 54.6% of FY24 revenue); annualising HY25 revenue gives $392.1m, roughly 18% below FY24's $479.1m, so the current run-rate implies a materially lower full-year top line unless 2H25 steps up. FY24 itself was heavily first-half weighted on earnings (HY24 was 67.5% of full-year EBITDA and more than 100% of NPAT), meaning 2H24 was already weak — so the HY25 base rate of $0.6m EBITDA does not have an obvious seasonal tailwind behind it. Management commentary pointed to weak economic conditions rather than a specific inflection.
Quality of result
The $23.1m of operating cash flow is disproportionately working-capital driven: with EBITDA at $0.6m, essentially all of operating cash flow came from inventory and receivables running down as revenue contracted. That source of cash is finite — once inventory normalises to the new volume level, operating cash flow will converge toward the earnings result. Free cash flow of $19.3m comfortably exceeded the (absent) dividend and funded the cash impact of the acquisition reference, but it is not evidence of durable underlying cash generation. The PBT-to-NPAT gap is explained by a tax credit on the loss, not by any discontinued operation or one-off disposal. No non-recurring items were flagged in the extraction, so the reported earnings weakness should be read as underlying.
Unresolved
- The size, price, earnings contribution and funding mix of the acquisition referenced in the release header are not visible in the supplied data.
- There is no gross margin disclosure, so it is not possible to separate volume, price and input-cost effects within the 25.1% revenue decline.
- Segment-level HY25 revenue and result are not in the extraction, so the relative performance of Distribution versus Infrastructure over the half cannot be assessed.
- Forward order book, pipeline, or any quantified cost-out progress (the previously flagged $5m programme) are not disclosed here.
- The rationale for suspending the interim dividend — whether acquisition-related, trading-related, or both — is not explicitly tied to either driver in the supplied text.
This briefing cannot assess the economics of the announced acquisition or any updated management guidance beyond what is contained in the supplied extraction.
Key metrics
| Metric | HY25 | HY24 | Change |
|---|---|---|---|
| Revenue | $196.0m | $261.8m | -25.1% ↓ |
| EBITDA | $0.6m | $21.2m | -97.2% ↓ |
| Net profit after tax | −$10.4m | $5.3m | -294.4% ↓ |
| Net cash inflow from operating activities | $23.1m | $38.7m | -40.2% ↓ |
| Interim dividend per share | — | 4.0c | — |
| Operating profit | −$10.9m | $10.2m | -207.4% ↓ |
| Profit before tax | −$14.3m | $7.5m | -290.5% ↓ |
| Cash and cash equivalents | $17.5m | $26.3m | -33.3% ↓ |
| Total assets | $334.3m | $350.2m | -4.5% ↓ |
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Distribution | — | $153.1m | — | n/a |
| Infrastructure | — | $108.6m | — | n/a |
Analytical metrics
| Metric | HY25 | HY24 | Context |
|---|---|---|---|
| Effective tax rate | n/m (loss period) | -28.6% | current loss period |
| OCF / EBITDA (cash conversion) | n/m | 182.6% | stable |
| FCF pre-lease | $19.3m | $34.3m | −$15.0m |
| FCF post-lease | $19.3m | $34.3m | −$15.0m |
| FCF / NPAT | -185.3% | 640.6% | complementary conversion metric |
| Capex % revenue | 2.0% | 1.7% | — |
| Capex | −$3.9m | −$4.4m | +$0.6m |
| Debtor days | 39.0 | 38.0 | +1.0 days |
| Inventory days | 101.8 | 89.4 | +12.4 days |
| Trade debtors | $42.0m | $54.7m | −$12.7m |
| Net debt | −$17.5m | −$26.3m | +$8.7m |
| Net debt / EBITDA | -29.19x | -1.24x | Weakening |
| Payout ratio vs NPAT | 0.0% | — | — |
| Payout ratio vs FCF pre-lease | 0.0% | — | covered |
| ROE (annualised) | -5.6% | 2.6% | Weakening |
| HY24 share of FY24 revenue | 54.6% | — | Other half was 45.4% |
| HY24 share of FY24 EBITDA | 67.5% | — | Other half was 32.5% |
| HY24 share of FY24 NPAT | 202.6% | — | Other half was -102.6% |
| Profit from continuing operations | −$10.4m | $5.3m | −$15.7m |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.